Literature DB >> 29360650

Exploring Nitrous Oxide as Treatment of Mood Disorders: Basic Concepts.

Peter Nagele, Charles F Zorumski, Charles Conway.   

Abstract

Nitrous oxide (laughing gas) has shown early promise as a rapidly acting antidepressant in patients with treatment-resistant major depression and is currently investigated in several clinical trials. Because nitrous oxide is rarely administered outside operating rooms or dental practices, most psychiatrists are not familiar with how nitrous oxide is administered in a medical setting and what regulations guide its use. The goal of this brief review was to educate psychiatrists about the basic concepts of nitrous oxide administration and pharmacology. Furthermore, common misconceptions about nitrous oxide will be discussed.

Entities:  

Mesh：

Substances：

Year:  2018        PMID： 29360650      PMCID： PMC5825282          DOI： 10.1097/JCP.0000000000000837

Source DB:  PubMed          Journal:  J Clin Psychopharmacol        ISSN： 0271-0749            Impact factor:   3.153


  44 in total

1.  Inhalant abuse and dependence among adolescents in the United States.

Authors:  Li-Tzy Wu; Daniel J Pilowsky; William E Schlenger
Journal:  J Am Acad Child Adolesc Psychiatry       Date:  2004-10       Impact factor: 8.829

2.  Effect of N-methyl-D-aspartate receptor epsilon1 subunit gene disruption of the action of general anesthetic drugs in mice.

Authors:  Yuki Sato; Eiji Kobayashi; Takanori Murayama; Masayoshi Mishina; Norimasa Seo
Journal:  Anesthesiology       Date:  2005-03       Impact factor: 7.892

3.  Up: The rise of nitrous oxide abuse. An international survey of contemporary nitrous oxide use.

Authors:  Stephen J Kaar; Jason Ferris; Jon Waldron; Madonna Devaney; John Ramsey; Adam R Winstock
Journal:  J Psychopharmacol       Date:  2016-02-24       Impact factor: 4.153

Review 4.  Clinical aspects of the interaction between nitrous oxide and vitamin B12.

Authors:  J F Nunn
Journal:  Br J Anaesth       Date:  1987-01       Impact factor: 9.166

5.  Efficacy and safety of nitrous oxide in alleviating pain and anxiety during painful procedures.

Authors:  S A Kanagasundaram; L J Lane; B P Cavalletto; J P Keneally; M G Cooper
Journal:  Arch Dis Child       Date:  2001-06       Impact factor: 3.791

6.  The impact of NMDA receptor blockade on human working memory-related prefrontal function and connectivity.

Authors:  Naomi R Driesen; Gregory McCarthy; Zubin Bhagwagar; Michael H Bloch; Vincent D Calhoun; Deepak C D'Souza; Ralitza Gueorguieva; George He; Hoi-Chung Leung; Ramachandran Ramani; Alan Anticevic; Raymond F Suckow; Peter T Morgan; John H Krystal
Journal:  Neuropsychopharmacology       Date:  2013-07-16       Impact factor: 7.853

7.  Effect of nitrous oxide on excitatory and inhibitory synaptic transmission in hippocampal cultures.

Authors:  S Mennerick; V Jevtovic-Todorovic; S M Todorovic; W Shen; J W Olney; C F Zorumski
Journal:  J Neurosci       Date:  1998-12-01       Impact factor: 6.167

Review 8.  New paradigms for treatment-resistant depression.

Authors:  Carlos Zarate; Ronald S Duman; Guosong Liu; Simone Sartori; Jorge Quiroz; Harald Murck
Journal:  Ann N Y Acad Sci       Date:  2013-07       Impact factor: 5.691

Review 9.  The role of NMDA receptors in the pathophysiology and treatment of mood disorders.

Authors:  Mehdi Ghasemi; Cristy Phillips; Ludwig Trillo; Zurine De Miguel; Devsmita Das; Ahmad Salehi
Journal:  Neurosci Biobehav Rev       Date:  2014-09-16       Impact factor: 8.989

Review 10.  Nitrous Oxide, From the Operating Room to the Emergency Department.

Authors:  Christine Huang; Nathaniel Johnson
Journal:  Curr Emerg Hosp Med Rep       Date:  2016-03-22
View more
  7 in total

Review 1.  Intrinsic Connectivity Networks of Glutamate-Mediated Antidepressant Response: A Neuroimaging Review.

Authors:  Ilya Demchenko; Vanessa K Tassone; Sidney H Kennedy; Katharine Dunlop; Venkat Bhat
Journal:  Front Psychiatry       Date:  2022-05-26       Impact factor: 5.435

2.  Does Nitrous Oxide Help Veterans With Posttraumatic Stress Disorder? A Case Series.

Authors:  Andrea Varias; Peter van Roessel; Maryam Parsiani; Maria Filippou-Frye; Thomas C Neylan; Peter Nagele; Jerome Yesavage; J David Clark; Carolyn I Rodriguez
Journal:  J Clin Psychiatry       Date:  2020-06-30       Impact factor: 4.384

3.  Nitrous oxide as a putative novel dual-mechanism treatment for bipolar depression: Proof-of-concept study design and methodology.

Authors:  Mikaela K Dimick; Danielle Omrin; Bradley J MacIntosh; Rachel H B Mitchell; Daniel Riegert; Anthony Levitt; Ayal Schaffer; Susan Belo; John Iazzetta; Garfield Detzler; Mabel Choi; Stephen Choi; Beverley A Orser; Benjamin I Goldstein
Journal:  Contemp Clin Trials Commun       Date:  2020-06-23

4.  Pharmacological modelling of dissociation and psychosis: an evaluation of the Clinician Administered Dissociative States Scale and Psychotomimetic States Inventory during nitrous oxide ('laughing gas')-induced anomalous states.

Authors:  Giulia G Piazza; Georges Iskandar; Vanessa Hennessy; Hannah Zhao; Katie Walsh; Jeffrey McDonnell; Devin B Terhune; Ravi K Das; Sunjeev K Kamboj
Journal:  Psychopharmacology (Berl)       Date:  2022-03-26       Impact factor: 4.415

5.  What is better for psychiatry: Titrated or fixed concentrations of nitrous oxide?

Authors:  Mark A Gillman
Journal:  Front Psychiatry       Date:  2022-08-22       Impact factor: 5.435

Review 6.  Novel drug developmental strategies for treatment-resistant depression.

Authors:  Éva Borbély; Mária Simon; Eberhard Fuchs; Ove Wiborg; Boldizsár Czéh; Zsuzsanna Helyes
Journal:  Br J Pharmacol       Date:  2022-01-26       Impact factor: 9.473

7.  Rewarding Subjective Effects of the NMDAR Antagonist Nitrous Oxide (Laughing Gas) Are Moderated by Impulsivity and Depressive Symptoms in Healthy Volunteers.

Authors:  Sunjeev K Kamboj; Hannah Zhao; Luzia Troebinger; Giulia Piazza; Emma Cawley; Vanessa Hennessy; Georges Iskandar; Ravi K Das
Journal:  Int J Neuropsychopharmacol       Date:  2021-07-23       Impact factor: 5.176
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.